ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DHC vs MS // GROSS PROFIT MARGIN

Diversified Healthcare Trust of (NASDAQ) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: DHC 2 — MS 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DHC VS. MS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DHC MS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -17.20% 3.00% -20.20 MS /roic <GO>
EV/EBITDA & P/E Valuation — 31.0x — TIE /valuation <GO>
Free Cash Flow Yield -1.02% -7.25% +6.23 DHC /fcf-yield <GO>
Operating Margin — 24.60% — TIE /operating-margins <GO>
Net Profit Margin -18.60% 20.20% -38.80 MS /net-margins <GO>
Revenue Growth (YoY) 2.80% 5.50% -2.70 MS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.50% 2.21% -1.71 MS /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 5/9 -3.00 MS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.6 51.0 +5.60 DHC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.04 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 16.5x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.93B $298.41B -$296.48B MS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DHC REV MS REV DHC GROSS % MS GROSS % DHC FCF MS FCF
FY 2025 $1.54B $0 — — -$19.6M -$17.89B
FY 2024 $1.50B $0 — — $112.2M $1.36B
FY 2023 $1.41B $0 — — $10.5M -$33.54B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DHC // BETA —
MS // BETA 1.04